Table 1.
Characteristics of Study Cohorts
| Characteristics | COVID-19 (n = 24) | Lung disease severity | Healthy (n = 23) | p valuea | |
|---|---|---|---|---|---|
| Minimal (n = 14) | Mod/Severe (n = 10) | ||||
| Age (years) | 41.7 (28.0–62.3) | 39.7 (27.1–64.5) | 44.8 (30.5–59.3) | 41 (30.0–48.5) | 0.799 |
| Female | 10 (42%) | 6 (43%) | 4 (40%) | 12 (52%) | 0.382 |
| BMI (kg/m2) | 27.9 (24.9–36.4) | 27.9 (24.3–35.8) | 27.9 (25.4–44.0) | 0.989 | |
| Ethnicity | 0.778 | ||||
| Hispanic | 8 (33%) | 5 (36%) | 3 (30%) | 5 (22%) | |
| Non-Hispanic | 16 (67%) | 9 (64%) | 7 (70%) | 18 (78%) | |
| Race | 0.584 | ||||
| White | 16 (67%) | 10 (71%) | 6 (60%) | 16 (70%) | |
| Black | 3 (13%) | 1 (7%) | 2 (20%) | 2 (8%) | |
| Asian | 1 (4%) | 1 (7%) | 0 (0%) | 5 (21%) | |
| Other | 2 (8%) | 1 (7%) | 1 (10%) | 0 (0%) | |
| Unknown | 2 (8%) | 1 (7%) | 1 (10%) | 0 (0%) | |
| Length of stay from symptom onset (days) | 12 (9–15) | 12 (9–13.2) | 14 (8–15) | 0.967 | |
| Day of sample acquisition | 3 (2–3) | 3 (2–3) | 2.5 (1–3) | 0.403 | |
Categorical values are presented as n (%) and continuous values are presented as median (interquartile range).
BMI body mass index.
ap values calculated using one-way ANOVA and chi-squared analysis as appropriate.